histone deacetylase (HDAC) inhibitors
Description Results NMA

pathology

treatment

patient

Demonstrated benefit and harm

k

advanced breast cancer (metastatic)

entinostat

not classified

versus endocrine therapy alone

No demonstrated result for efficacy